ID   VP1_POVJC               Reviewed;         354 AA.
AC   P03089;
DT   21-JUL-1986, integrated into UniProtKB/Swiss-Prot.
DT   21-JUL-1986, sequence version 1.
DT   03-AUG-2022, entry version 121.
DE   RecName: Full=Major capsid protein VP1;
DE   AltName: Full=Major structural protein VP1;
OS   JC polyomavirus (JCPyV) (JCV).
OC   Viruses; Monodnaviria; Shotokuvirae; Cossaviricota; Papovaviricetes;
OC   Sepolyvirales; Polyomaviridae; Betapolyomavirus.
OX   NCBI_TaxID=10632;
OH   NCBI_TaxID=9606; Homo sapiens (Human).
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=MAD-1;
RX   PubMed=6086957; DOI=10.1128/jvi.51.2.458-469.1984;
RA   Frisque R.J., Bream G.L., Cannella M.T.;
RT   "Human polyomavirus JC virus genome.";
RL   J. Virol. 51:458-469(1984).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=C1, CY, G2, G3, HER1-BR, MAD11-BR, MAD8-BR, MY, N1, N4, NY-1B,
RC   and Tokyo-1;
RX   PubMed=8389465; DOI=10.1073/pnas.90.11.5062;
RA   Iida T., Kitamura T., Guo J., Taguchi F., Aso Y., Nagashima K., Yogo Y.;
RT   "Origin of JC polyomavirus variants associated with progressive multifocal
RT   leukoencephalopathy.";
RL   Proc. Natl. Acad. Sci. U.S.A. 90:5062-5065(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=NY-1B;
RX   PubMed=7915447; DOI=10.1007/bf01703608;
RA   Yogo Y., Guo J., Iida T., Satoh K.I., Taguchi F., Takahashi H., Hall W.W.,
RA   Nagashima K.;
RT   "Occurrence of multiple JC virus variants with distinctive regulatory
RT   sequences in the brain of a single patient with progressive multifocal
RT   leukoencephalopathy.";
RL   Virus Genes 8:99-105(1994).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   STRAIN=AIC-1A, TKY-2A, and YI;
RX   PubMed=7823412; DOI=10.7883/yoken1952.47.167;
RA   Kato K., Guo J., Taguchi F., Daimaru O., Tajima T., Haibara H., Matsuda J.,
RA   Sumiya S., Yogo Y.;
RT   "Phylogenetic comparison between archetypal and disease-associated JC virus
RT   isolates in Japan.";
RL   Jpn. J. Med. Sci. Biol. 47:167-178(1994).
RN   [5]
RP   FUNCTION.
RX   PubMed=9573227; DOI=10.1128/jvi.72.6.4643-4649.1998;
RA   Liu C.K., Wei G., Atwood W.J.;
RT   "Infection of glial cells by the human polyomavirus JC is mediated by an N-
RT   linked glycoprotein containing terminal alpha(2-6)-linked sialic acids.";
RL   J. Virol. 72:4643-4649(1998).
RN   [6]
RP   FUNCTION.
RX   PubMed=10666259; DOI=10.1128/jvi.74.5.2288-2292.2000;
RA   Pho M.T., Ashok A., Atwood W.J.;
RT   "JC virus enters human glial cells by clathrin-dependent receptor-mediated
RT   endocytosis.";
RL   J. Virol. 74:2288-2292(2000).
RN   [7]
RP   NUCLEAR LOCALIZATION SIGNAL.
RX   PubMed=15069063; DOI=10.1074/jbc.m310827200;
RA   Qu Q., Sawa H., Suzuki T., Semba S., Henmi C., Okada Y., Tsuda M.,
RA   Tanaka S., Atwood W.J., Nagashima K.;
RT   "Nuclear entry mechanism of the human polyomavirus JC virus-like particle:
RT   role of importins and the nuclear pore complex.";
RL   J. Biol. Chem. 279:27735-27742(2004).
RN   [8]
RP   INTERACTION WITH HOST 5HT2AR.
RX   PubMed=15550673; DOI=10.1126/science.1103492;
RA   Elphick G.F., Querbes W., Jordan J.A., Gee G.V., Eash S., Manley K.,
RA   Dugan A., Stanifer M., Bhatnagar A., Kroeze W.K., Roth B.L., Atwood W.J.;
RT   "The human polyomavirus, JCV, uses serotonin receptors to infect cells.";
RL   Science 306:1380-1383(2004).
RN   [9]
RP   REVIEW.
RX   PubMed=19157477; DOI=10.1016/j.virol.2008.12.022;
RA   Sapp M., Day P.M.;
RT   "Structure, attachment and entry of polyoma- and papillomaviruses.";
RL   Virology 384:400-409(2009).
RN   [10]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15331723; DOI=10.1128/jvi.78.18.9890-9903.2004;
RA   Shishido-Hara Y., Ichinose S., Higuchi K., Hara Y., Yasui K.;
RT   "Major and minor capsid proteins of human polyomavirus JC cooperatively
RT   accumulate to nuclear domain 10 for assembly into virions.";
RL   J. Virol. 78:9890-9903(2004).
RN   [11]
RP   REVIEW.
RX   PubMed=19157478; DOI=10.1016/j.virol.2008.12.021;
RA   Neu U., Stehle T., Atwood W.J.;
RT   "The Polyomaviridae: Contributions of virus structure to our understanding
RT   of virus receptors and infectious entry.";
RL   Virology 384:389-399(2009).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 23-290 IN COMPLEX WITH LINEAR
RP   SIALYLATED PENTASACCHARIDE.
RX   PubMed=20951965; DOI=10.1016/j.chom.2010.09.004;
RA   Neu U., Maginnis M.S., Palma A.S., Stroeh L.J., Nelson C.D., Feizi T.,
RA   Atwood W.J., Stehle T.;
RT   "Structure-function analysis of the human JC polyomavirus establishes the
RT   LSTc pentasaccharide as a functional receptor motif.";
RL   Cell Host Microbe 8:309-319(2010).
CC   -!- FUNCTION: Forms an icosahedral capsid with a T=7 symmetry and a 40 nm
CC       diameter. The capsid is composed of 72 pentamers linked to each other
CC       by disulfide bonds and associated with VP2 or VP3 proteins. Interacts
CC       with a N-linked glycoprotein containing terminal alpha(2-6)-linked
CC       sialic acids on the cell surface to provide virion attachment to target
CC       cell. The serotonergic receptor 5HT2AR also acts as a cellular receptor
CC       for JCV on human glial cells. Once attached, the virions enter
CC       predominantly by a ligand-inducible clathrin-dependent pathway and
CC       traffic to the ER. Inside the endoplasmic reticulum, the protein
CC       folding machinery isomerizes VP1 interpentamer disulfide bonds, thereby
CC       triggering initial uncoating. Next, the virion uses the endoplasmic
CC       reticulum-associated degradation machinery to probably translocate in
CC       the cytosol before reaching the nucleus. Nuclear entry of the viral DNA
CC       involves the selective exposure and importin recognition of VP2/Vp3
CC       nuclear localization signal. In late phase of infection, neo-
CC       synthesized VP1 encapsulates replicated genomic DNA at nuclear domains
CC       called promyelocytic leukemia (PML) bodies, and participates in
CC       rearranging nucleosomes around the viral DNA.
CC       {ECO:0000269|PubMed:10666259, ECO:0000269|PubMed:9573227,
CC       ECO:0000305|PubMed:19157478}.
CC   -!- SUBUNIT: Homomultimer; disulfide-linked. The virus capsid is composed
CC       of 72 icosahedral units, each one composed of five disulfide-linked
CC       copies of VP1. Interacts with minor capsid proteins VP2 and VP3 (By
CC       similarity). Interacts with host 5HT2AR. {ECO:0000250,
CC       ECO:0000269|PubMed:15550673, ECO:0000269|PubMed:20951965}.
CC   -!- SUBCELLULAR LOCATION: Virion. Host nucleus
CC       {ECO:0000269|PubMed:15331723}. Note=Virions are efficiently assembled
CC       at nuclear domain 10 (ND10), which is also known as promyelocytic
CC       leukemia (PML) nuclear bodies. {ECO:0000269|PubMed:15331723}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing, Alternative initiation; Named isoforms=5;
CC       Name=VP1; Synonyms=Major capsid protein VP1;
CC         IsoId=P03089-1; Sequence=Displayed;
CC       Name=VP2; Synonyms=Minor capsid protein VP2;
CC         IsoId=P03095-1; Sequence=External;
CC       Name=VP3; Synonyms=Minor capsid protein VP3;
CC         IsoId=P03095-2; Sequence=External;
CC       Name=VP4; Synonyms=Viroporin VP4;
CC         IsoId=P03095-3; Sequence=External;
CC       Name=Agno;
CC         IsoId=P03086-1; Sequence=External;
CC   -!- DOMAIN: The intrinsically disordered C-terminal arm interacts with
CC       neighboring pentamers. The unstructured nature of this region allows to
CC       make different interactions depending on the structural context:
CC       pentamers present at the 12 icosahedral fivefold axes bind five
CC       pentamers, whereas pentamers present at the 60 icosahedral six-fold
CC       axes interact with six pentamers. {ECO:0000250|UniProtKB:P03087}.
CC   -!- MISCELLANEOUS: [Isoform VP1]: Produced by alternative splicing of the
CC       late mRNA.
CC   -!- SIMILARITY: Belongs to the polyomaviruses coat protein VP1 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; J02226; AAA82101.1; -; Genomic_DNA.
DR   EMBL; D11356; BAA01958.1; -; Genomic_DNA.
DR   EMBL; D11357; BAA01959.1; -; Genomic_DNA.
DR   EMBL; D11358; BAA01960.1; -; Genomic_DNA.
DR   EMBL; D11359; BAA01961.1; -; Genomic_DNA.
DR   EMBL; D11360; BAA01962.1; -; Genomic_DNA.
DR   EMBL; D11361; BAA01963.1; -; Genomic_DNA.
DR   EMBL; D11362; BAA01964.1; -; Genomic_DNA.
DR   EMBL; D11363; BAA01965.1; -; Genomic_DNA.
DR   EMBL; D11364; BAA01966.1; -; Genomic_DNA.
DR   EMBL; D11365; BAA01967.1; -; Genomic_DNA.
DR   EMBL; D11366; BAA01968.1; -; Genomic_DNA.
DR   EMBL; D11368; BAA01970.1; -; Genomic_DNA.
DR   EMBL; D26589; BAA05636.1; -; Genomic_DNA.
DR   EMBL; D26591; BAA05638.1; -; Genomic_DNA.
DR   EMBL; D26592; BAA05639.1; -; Genomic_DNA.
DR   PIR; A03626; VVVP1J.
DR   RefSeq; NP_043511.1; NC_001699.1. [P03089-1]
DR   PDB; 3NXD; X-ray; 2.00 A; A/B/C/D/E=23-290.
DR   PDB; 3NXG; X-ray; 1.95 A; A/B/C/D/E=23-290.
DR   PDB; 4JCD; X-ray; 2.00 A; A/B/C/D/E=23-290.
DR   PDB; 4JCE; X-ray; 1.90 A; A/B/C/D/E=23-290.
DR   PDB; 4JCF; X-ray; 2.20 A; A/B/C/D/E=23-290.
DR   PDB; 4WDY; X-ray; 1.90 A; A/B/C/D/E=23-290.
DR   PDB; 4WDZ; X-ray; 1.80 A; A/B/C/D/E=23-290.
DR   PDB; 4WE0; X-ray; 2.10 A; A/B/C/D/E=23-290.
DR   PDB; 4X14; X-ray; 2.30 A; A/B/C/D/E=23-290.
DR   PDB; 4X15; X-ray; 2.11 A; A/B/C/D/E=23-290.
DR   PDB; 4X16; X-ray; 1.80 A; A/B/C/D/E=23-290.
DR   PDB; 4X17; X-ray; 1.75 A; A/B/C/D/E=23-290.
DR   PDBsum; 3NXD; -.
DR   PDBsum; 3NXG; -.
DR   PDBsum; 4JCD; -.
DR   PDBsum; 4JCE; -.
DR   PDBsum; 4JCF; -.
DR   PDBsum; 4WDY; -.
DR   PDBsum; 4WDZ; -.
DR   PDBsum; 4WE0; -.
DR   PDBsum; 4X14; -.
DR   PDBsum; 4X15; -.
DR   PDBsum; 4X16; -.
DR   PDBsum; 4X17; -.
DR   SMR; P03089; -.
DR   UniLectin; P03089; -.
DR   PRIDE; P03089; -.
DR   DNASU; 1489518; -.
DR   GeneID; 1489518; -.
DR   KEGG; vg:1489518; -.
DR   EvolutionaryTrace; P03089; -.
DR   Proteomes; UP000008478; Genome.
DR   GO; GO:0042025; C:host cell nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0039620; C:T=7 icosahedral viral capsid; IEA:UniProtKB-KW.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0075512; P:clathrin-dependent endocytosis of virus by host cell; IEA:UniProtKB-KW.
DR   GO; GO:0019062; P:virion attachment to host cell; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.175.10; -; 1.
DR   InterPro; IPR000662; Capsid_VP1_Polyomavir.
DR   InterPro; IPR011222; dsDNA_vir_gr_I_capsid.
DR   InterPro; IPR036931; Polyomavir_VP1_sf.
DR   Pfam; PF00718; Polyoma_coat; 1.
DR   PIRSF; PIRSF003376; Capsid_VP1_Polyomavir; 1.
DR   SUPFAM; SSF88648; SSF88648; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative initiation; Alternative splicing; Capsid protein;
KW   Clathrin-mediated endocytosis of virus by host; Disulfide bond;
KW   Host nucleus; Host-virus interaction; Late protein; Phosphoprotein;
KW   T=7 icosahedral capsid protein; Viral attachment to host cell;
KW   Viral penetration into host cytoplasm; Virion; Virus endocytosis by host;
KW   Virus entry into host cell.
FT   CHAIN           1..354
FT                   /note="Major capsid protein VP1"
FT                   /id="PRO_0000115021"
FT   REGION          294..354
FT                   /note="C-terminal arm"
FT                   /evidence="ECO:0000250|UniProtKB:P03087"
FT   MOD_RES         330
FT                   /note="Phosphothreonine; by host"
FT                   /evidence="ECO:0000250"
FT   DISULFID        97
FT                   /note="Interchain (with C-97)"
FT                   /evidence="ECO:0000250"
FT   VARIANT         66
FT                   /note="D -> H (in strain: Isolate MAD11-BR)"
FT   VARIANT         74
FT                   /note="N -> S (in strain: Isolate NY-1B, Isolate N1 and
FT                   Isolate G3)"
FT   VARIANT         75
FT                   /note="R -> K (in strain: Isolate YI, Isolate TKY-2A,
FT                   Isolate MAD8-BR, Isolate HER1-BR, Isolate NY-1B, Isolate
FT                   N1, Isolate N4, Isolate G3, Isolate C1, Isolate CY, Isolate
FT                   MY, Isolate AIC-1A and Isolate Tokyo-1)"
FT   VARIANT         113
FT                   /note="I -> L (in strain: Isolate YI, Isolate C1, Isolate
FT                   AIC-1A and Isolate Tokyo-1)"
FT   VARIANT         117
FT                   /note="S -> T (in strain: Isolate YI, Isolate TKY-2A,
FT                   Isolate MAD8-BR, Isolate N4, Isolate C1, Isolate CY,
FT                   Isolate MY, Isolate AIC-1A and Isolate Tokyo-1)"
FT   VARIANT         128
FT                   /note="T -> A (in strain: Isolate MAD8-BR, Isolate NY-1B,
FT                   Isolate N1, Isolate G3 and Isolate N4)"
FT   VARIANT         158
FT                   /note="L -> V (in strain: Isolate YI, Isolate TKY-2A,
FT                   Isolate MAD8-BR, Isolate NY-1B, Isolate N1, Isolate N4,
FT                   Isolate G3, Isolate C1, Isolate CY, Isolate MY, Isolate
FT                   AIC-1A and Isolate Tokyo-1)"
FT   VARIANT         267
FT                   /note="S -> L (in strain: Isolate HER1-BR)"
FT   VARIANT         269
FT                   /note="S -> F (in strain: Isolate MAD8-BR)"
FT   VARIANT         269
FT                   /note="S -> T (in strain: Isolate YI)"
FT   VARIANT         269
FT                   /note="S -> Y (in strain: Isolate TKY-2A)"
FT   VARIANT         321
FT                   /note="V -> I (in strain: Isolate C1)"
FT   VARIANT         345
FT                   /note="K -> R (in strain: Isolate YI, Isolate TKY-2A,
FT                   Isolate MAD8-BR, Isolate N1, Isolate N4, Isolate G4,
FT                   Isolate C1, Isolate CY, Isolate MY, Isolate AIC-1A and
FT                   Isolate Tokyo-1)"
FT   STRAND          27..30
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   HELIX           34..36
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   STRAND          37..44
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   STRAND          65..68
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   HELIX           75..77
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   STRAND          82..87
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   STRAND          101..113
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   HELIX           115..119
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   STRAND          122..125
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   STRAND          127..129
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   STRAND          137..139
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   STRAND          141..150
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   STRAND          153..156
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   HELIX           177..180
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   STRAND          187..189
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   TURN            193..195
FT                   /evidence="ECO:0007829|PDB:4JCE"
FT   HELIX           198..200
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   STRAND          201..203
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   STRAND          211..218
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   STRAND          226..232
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   HELIX           248..250
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   STRAND          251..265
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   STRAND          270..274
FT                   /evidence="ECO:0007829|PDB:4X17"
FT   STRAND          276..288
FT                   /evidence="ECO:0007829|PDB:4X17"
SQ   SEQUENCE   354 AA;  39609 MW;  33CDA3DD93026ED0 CRC64;
     MAPTKRKGER KDPVQVPKLL IRGGVEVLEV KTGVDSITEV ECFLTPEMGD PDEHLRGFSK
     SISISDTFES DSPNRDMLPC YSVARIPLPN LNEDLTCGNI LMWEAVTLKT EVIGVTSLMN
     VHSNGQATHD NGAGKPVQGT SFHFFSVGGE ALELQGVLFN YRTKYPDGTI FPKNATVQSQ
     VMNTEHKAYL DKNKAYPVEC WVPDPTRNEN TRYFGTLTGG ENVPPVLHIT NTATTVLLDE
     FGVGPLCKGD NLYLSAVDVC GMFTNRSGSQ QWRGLSRYFK VQLRKRRVKN PYPISFLLTD
     LINRRTPRVD GQPMYGMDAQ VEEVRVFEGT EELPGDPDMM RYVDKYGQLQ TKML
//
